HighTower Advisors’s Eli Lilly LLY Stock Holding History

HighTower Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-200	Closed	-$8.71K	–	3960
2025 Q2	$8.71K	Buy	+200	New	+$155K	﹤0.01%	3654
2025 Q1	–	Sell	-100	Closed	-$14.2K	–	3913
2024 Q4	$14.2K	Sell	100 -100	-50%	-$82.8K	﹤0.01%	3566
2024 Q3	$32.7K	Sell	200 -200	-50%	-$180K	﹤0.01%	3463
2024 Q2	$83.2K	Sell	400 -9,900	-96%	-$7.92M	﹤0.01%	3237
2024 Q1	$52.9K	Buy	+10,300	New	+$7.33M	﹤0.01%	3249
2022 Q2	–	Sell	-3	Closed	-$7K	–	3414
2022 Q1	$7K	Buy	+3	New	+$772	﹤0.01%	3238
2020 Q2	–	Sell	-1,000	Closed	-$7K	–	2490
2020 Q1	$7K	Buy	+1,000	New	+$137K	﹤0.01%	2136
2014 Q2	–	Sell	-500	Closed	-$2K	–	1666
2014 Q1	$2K	Buy	+500	New	+$27.9K	﹤0.01%	1560

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

HighTower Advisors's LLY Position: Q1 2026 in Review

HighTower Advisors reduced its Eli Lilly (LLY) stake by 9.6% in Q1 2026, selling an estimated $47.6M and leaving 440,797 shares worth $406M. The position accounts for 0.43% of the portfolio, ranked #40.

HighTower Advisors first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $524M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

HighTower Advisors held 440,797 shares of Eli Lilly worth $406M as of Q1 2026.
HighTower Advisors sold 46,925 Eli Lilly shares in Q1 2026, an estimated $47.6M.
Eli Lilly made up 0.43% of HighTower Advisors's portfolio in Q1 2026, its #40 holding.
HighTower Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
HighTower Advisors's Eli Lilly position peaked at $524M in Q4 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.